Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treat decision making in catastrophic illness.

K E Warner

    Medical Care
    |January 1, 1977
    PubMed
    Summary

    Physicians may adopt innovative treatments for serious illnesses based on trends and the "social contract," not just proven efficacy or cost. This contrasts with typical innovation adoption, especially in catastrophic care settings.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The global tobacco disease pandemic: nature, causes, and cures.

    Global public health·2009
    Same author

    Tobacco harm reduction: what do the experts think?

    Tobacco control·2004
    Same author

    The US tobacco control community's view of the future of tobacco harm reduction.

    Tobacco control·2003
    Same author

    Innovative approaches to youth tobacco control: introduction and overview.

    Tobacco control·2003
    Same author

    Tobacco control policy: from action to evidence and back again.

    American journal of preventive medicine·2001
    Same author

    Smoking prevalence in 2010: why the healthy people goal is unattainable.

    American journal of public health·2000

    Area of Science:

    • Medical Economics
    • Health Services Research
    • Oncology

    Background:

    • Physician adoption of innovative medical treatments is influenced by various factors.
    • The economic environment of catastrophic illness care presents unique dynamics.
    • The

    Purpose of the Study:

    • To examine physician responses to new treatments for serious illnesses.
    • To analyze the role of economic factors and the medical social contract in treatment adoption.
    • To investigate the adoption patterns of innovative drug therapies for leukemia management.

    Main Methods:

    • Conceptual discussion integrating economic theory and medical ethics.
    • Case study analysis of leukemia treatment trends in Connecticut.
    • Statistical analysis of variables influencing treatment decisions.

    Main Results:

    • Innovative therapies for catastrophic illnesses may be adopted pre-efficacy due to economic and social factors.
    • Leukemia treatment decisions were driven by trends rather than inherent therapy merits.
    • Patient economic status influenced chemotherapy receipt differently across leukemia types.

    Conclusions:

    • The adoption of innovative medical treatments is complex, influenced by factors beyond cost and efficacy.
    • Social contract and economic incentives can drive early adoption of novel therapies.
    • Treatment trends, rather than evidence, may guide adoption in certain serious illness contexts.

    Related Experiment Videos